Assyro AI

FDA Orange Book · active-ingredient family

Lindane

Lindane is approved as 2 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:KWELL · NDA 006309

2

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, lotion, shampoo

ProductApplicantApplicationTEApproved
KWELL×2REED AND CARNRICKNDA 006309Approved Prior to Jan 1, 1982
KWELLREED AND CARNRICKNDA 010718Approved Prior to Jan 1, 1982

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
LINDANEWOCKHARDT BIO AGANDA 088191Sep 18, 1984
LINDANEWOCKHARDT BIO AGANDA 088190Aug 16, 1984
SCABENESTIEFELANDA 087940Apr 08, 1983
KWELL×2REED AND CARNRICKANDA 084218Approved Prior to Jan 1, 1982
GAMENESOLA BARNES HINDANDA 084989Approved Prior to Jan 1, 1982
LINDANEOLTA PHARMSANDA 087313Approved Prior to Jan 1, 1982
SCABENESTIEFELANDA 086769Approved Prior to Jan 1, 1982
GAMENESOLA BARNES HINDANDA 084988Approved Prior to Jan 1, 1982
KWELLREED AND CARNRICKANDA 084219Approved Prior to Jan 1, 1982
LINDANEOLTA PHARMSANDA 087266Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Lindane — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.